HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Sanofi

This article was originally published in The Rose Sheet

Executive Summary

Sanofi: Yves Rocher and Nina Ricci subsidiaries "registered good performances" for the first half of 1995 "with sales growth of more than 6%," the Paris-based company announces July 24. Overall perfume and beauty product revenues declined 16.2% to $403.7 mil. (based on June 30, 1995 exchange rate of $1 = FFr 4.8405). The double-digit decline, Sanofi explains, takes into account the divestment of the Stendhal, Perry Ellis and Geoffrey Beene brands, as well as "measures taken with regard to the selective distribution of major brands." The company noted that, on a comparable basis, sales for the segment only declined 6.1%. Perfumes and beauty products represent 15.9% of the firm's $2.54 bil. (down 7.7%) in sales for the first half. Sanofi said it plans to release first half earnings results "at the end of August" and expects to "register a satisfactory increase" over the year-ago figure...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001866

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel